SCHEMBL2942889

SCHEMBL2942889

CC(C)Cn1cc[n+](C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33
APAF1 O14727 1/20 0.33
NPC1 O15118 1/20 0.33
PLA2G1B P04054 1/20 0.33
HSP90AA1 P07900 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ATG4B Q9Y4P1 1/20 0.33
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29424981 0.84 FDPS (0.39) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL372352 0.84 SMN1; SMN2 (0.38) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL29434929 0.84 SMN1; SMN2 (0.38) FDPSSMN1; SMN2MEN1APAF1NPC1
Lithium SCHEMBL29973484 0.82 SMN1; SMN2 (0.37) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL2934584 0.82 FDPS (0.40) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL29395782 0.81 SMN1; SMN2 (0.46) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL30193788 0.80 FDPS (0.33) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL3678674 0.80 SMN1; SMN2 (0.39) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL422564 0.79 FDPS (0.50) FDPSSMN1; SMN2MEN1APAF1NPC1
SCHEMBL2691328 0.79 FDPS (0.33) FDPSSMN1; SMN2MEN1APAF1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3094323-A2 METHODS AND COMPOSITIONS FOR MODULATING HORMONE LEVELS Ligand Pharmaceuticals Incorporated (US) 2016-11-23 EP disclosed
WO-2015108988-A2 METHODS AND COMPOSITIONS FOR MODULATING HORMONE LEVELS LIGAND PHARMACEUTICALS, INC. (US) 2015-07-23 WO disclosed
EP-2222636-A2 SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF Ligand Pharmaceuticals Inc. (US) 2010-09-01 EP disclosed
WO-2009082437-A9 SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF LIGAND PHARMACEUTICALS INCORPORATED (US) 2010-08-12 WO disclosed
WO-2009082437-A2 SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF LIGAND PHARMACEUTICALS INCORPORATED (US) 2009-07-02 WO disclosed